Sigyn Therapeutics Inc (PK)【SIGY】株式ニュース

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

The Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strategies...

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Presentation on Tuesday, October 21st at 4:00 PM PTSan Diego, California--(Newsfile Corp. - October 21, 2025) - Sigyn Therapeutics, Inc. (OTCQB:...

Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Presentation on Tuesday, October 21st at 4:00 PM PTSan Diego, California--(Newsfile Corp. - October 17, 2025) - Sigyn Therapeutics, Inc. (OTCQB:...

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

The $1.4 Trillion Cardiovascular Disease Crisis: Why Revolutionary Blood Purification Could Transform Treatment Access

Cardiovascular disease remains the world's leading cause of death, claiming more than 17.9 million lives annually according to the

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making

SAN DIEGO, CA -- March 12, 2025 -- InvestorsHub NewsWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:...

Form 8-K - Current report

SmallCapStockAlert 2週前

SHORT PATHWAY TO REVENUES
>Cardiovascular Disease
>Cancer Treatments
>Blood Purification
>Infectious Disease
>Inflammation
>BioDefense
>Ebola
https://richardacavalli.wixsite.com/greenplanetmicrocaps/market-overlooked-sigy

👍️0

SmallCapStockAlert 2週前

SIGY blood purification device gaining rapid industry attention: https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-bioterrorism-treatment

👍️0

SmallCapStockAlert 1月前

Sigyn Therapeutics: The Company Betting That the Future of Medicine Is Removing Disease — Not Just Treating It
https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-remove-disease

👍️0

SmallCapStockAlert 1月前

4 cent $SIGY NON DRUG new way to treat common illness is very short pathway. Even seems to cure #ebola. New LOI for licensing deal validates technology. https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-remove-disease

👍️0

SmallCapStockAlert 1月前

👍️0

SmallCapStockAlert 1月前

SIGY has discovered how to treat common medical conditions with NO DRUGS. This could be really big. And it is verified b the now of the recent LOI with Oragenics. https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-no-drugs

👍️0

SmallCapStockAlert 1月前

SURPRISE . . .https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-device-vs-drugs

👍️0

SmallCapStockAlert 1月前

New ebola outbreak could send shares soaring https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-ebola-plus

👍️0

SmallCapStockAlert 1月前

Unnoticed licensing deal with OGEN could drastically change the way common illnesses are treated. https://richardacavalli.wixsite.com/greenplanetmicrocaps/ogen-licensing-sigy

👍️0

hondaboost 2月前

Actually, it has Nothing to file because no revenue, no cash, but big cost the Scammer spent.

👍️0

hondaboost 2月前

NT-10K, it won't file 10K on time and go to Expert Market.

https://www.otcmarkets.com/filing/html?id=19307072&guid=DAS-kK_WEr7fJth

👍️0

SmallCapStockAlert 3月前

Could easily go back to $4 very quickly. And probably much higher than a deal is announced.

👍️0

SmallCapStockAlert 3月前

The entire market cap is under $300,000. Start calculating!

👍️0

SmallCapStockAlert 3月前

You don't know what you are talking about and are totally wrong. Stick around and watch. https://richardacavalli.wixsite.com/greenplanetmicrocaps/why-sigy

👍️0

SmallCapStockAlert 3月前

You don't know what you are talking about and are totally wrong. Stick around and watch. https://richardacavalli.wixsite.com/greenplanetmicrocaps/why-sigy

👍️0

hondaboost 3月前

Paid article for the huge Dilutions,

👍️0

SmallCapStockAlert 3月前

SIGY breaking into NFL https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-nfl-cte

👍️0

PennyStockTrader2 3月前

not a scam, far from it, granted they have had a huge amount of dilution as you pointed out, but not a scam. Could be a great play at these prices, we'll have to see.

👍️0

hondaboost 3月前

SIGY, This Scam is a Huge Diluting Machine: here:

O/S: 1.6 million, Feb 23, 2026
2.3 million, Mar 6, 2026
3.3 million, Mar 18, 2026
4.1 million, Mar 23, 2026
5.1 million, Mar 30, 2026.

And the scam is selling huge shares, EVERYDAY !!!

👍️0

hondaboost 3月前

Wow! SIGY, O/S increased to 5.1 Million shares. Diluted 1 million more shares in 1 week:

Outstanding Shares
5,156,004
03/30/2026

https://www.otcmarkets.com/stock/SIGY/security

O/S: 1.6 million, Feb 23, 2026
2.3 million, Mar 6, 2026
3.3 million, Mar 18, 2026
4.1 million, Mar 23, 2026
5.1 million, Mar 30, 2026.

👍️0

hondaboost 3月前

Serious Alert: This Scam is selling 1 Billion shares at any level.

👍️0

hondaboost 3月前

The Scam insider has been Notorious for stock Scam for years.

👍️0

hondaboost 3月前

Then, this Scam will do another Huge R/S, then, dumping, then, R/S......

👍️0

hondaboost 3月前

Warning: $0.01, this Scam is selling 1 Billion shares at any level.

👍️0

hondaboost 3月前

WOW! This Scam A/S: 1 Billion shares!!!

👍️0

hondaboost 3月前

Alert! This Scam/insiders dumping worthless shares at any level.

👍️0

hondaboost 3月前

Warning: SIGY did a few R/S: it did Huge R/S, then diluted, then did another Huge R/S, then diluted....repeating again and again.

Totally a Scam !!

👍️0

hondaboost 3月前

SIGY, totally a Scam! The Co. is a typical Diluting machine!

👍️0

hondaboost 3月前

Zut! SIGY, Diluting Machine: O/S: increased to 4.1 Milliion shares from 2.5 m in 2 weeks. and diluting Every day!!!

https://www.otcmarkets.com/stock/SIGY/security

👍️ 1

stock_observer_77 4月前

Nickel shares again....been watching last 2 days and I all I see is selling

👍️0

stock_observer_77 4月前

Hmmmmm

👍️0

stock_observer_77 4月前

No one even wants them for nickel

👍️0

hondaboost 4月前

SIGY, the CEO hints possible merger with NASDAQ listed Co.

👍️0

hondaboost 4月前

SIGY,$0.09. great news! O/S: 2.5 m, float: 221k. It was High as $5 in 2025. Bouncing back to $1's, then $2, 3, 4,...

https://www.otcmarkets.com/stock/SIGY/security

https://www.otcmarkets.com/stock/SIGY/news/Sigyn-Therapeutics-Issues-Shareholder-Update-Regarding-Potential-Merger-and-Asset-Sale-Initiatives?id=513809

👍️0

SmallCapStockAlert 4月前

Breakthrough blood purification technologies are emerging as one of the most important frontiers in medicine.
$SIGY may be positioning itself for a strategic merger that could reshape its future.
Full article:
https://richardacavalli.wixsite.com/greenplanetmicrocaps/sigy-merger

👍️0

SmallCapStockAlert 10月前

Sigyn vs. Statins: Better and Faster
Sigyn Therapy™ dramatically outperforms statins:
- Works in a single session versus weeks or months for statins.
- Lowers both LDL-C and Lp(a), unlike statins.
- Reduces inflammation and immediate MACE risk.
- Safe and effective for statin-intolerant patients.

👍️0

SmallCapStockAlert 1年前

ZERO Selling. No toxic shares. Deeply undervalued. Breakthrough treatment for dialysis and mainstream diseases. Short pathway to market. News could send shares flying soon. https://richardacavalli.wixsite.com/greenplanetmicrocaps/revolutionary-new-way-to-treat-disease

👍️0

SmallCapStockAlert 1年前

One little spark and $4 $SYGN will explode. Very tiny float and sellers are scarce. News for big dialysis companies like Davita and Fresenius is big and ready to ignite SIGY.
https://richardacavalli.wixsite.com/greenplanetmicrocaps/revolutionary-new-way-to-treat-disease

👍️0

SmallCapStockAlert 1年前

Fresenius and Davita are both likely to want this groundbreaking $SIGY blood cleansing technology that extends patient lives and increases revenue dramatically. $FMS $DVA https://richardacavalli.wixsite.com/greenplanetmicrocaps/revolutionary-new-way-to-treat-disease

👍️0

PennyStockTrader2 2年前

nothing has changed here except the company continues to make progress while the shares trade only by appointment it seems. Very very frustrating. As I have said before, the company ownership is mostly in the hands of the founders, so when the time comes, and I dont know when that is, the stock will move and move hard. If I get a large cash infusion I would put some in at these prices. But unfortunately trading the stock in the meantime is difficult with lack of liquidity.

🗑️ 1 🚽 1

Midwestrader 2年前

I wonder how many 1 share OTC transactions ANY zero commission broker would allow. Maybe just one trade that day?? So you get one share that would be worth $6.00 today but no one holding shares will be able to trade them for 1-4 days while the RS is sorted out by brokers. 99% of the time the pps tanks when no one will buy at 6.00. It could lose 50% in a day.

So when they could sell maybe they get 3.00 for their 15 cent buy?!?!

LOL!!

👍️0

Buckey 2年前

so 2000 folks bought 1 share each today lol all thinking they will not be reversed out and have one share after reverse worth $8. are there really that many no commision brokers?

I guessed at 2000 2800 trades and 45000 shares traded

The only no commission one I use doesn't allow most otc and penny stocks but I haven't tried lately. Maybe it said it in a filing. I have seen this a lot in the last year as I check daily list daily but how many do not actually reverse you out

👍️0

trader59 2年前

Y'know, on a leap year, we could add the day to any month we want.... I say we make a June 31...

👍️0

Renee 2年前

haha.....yup, just like Feb. 29th adds a day to Feb 28th I added a day to January.

Nuthin' gets by you, LOL.

Edited with thanks.

SIGY: effective Jan. 31,2024 a one for 40 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

👍️0

PennyStockTrader2 3年前

I continue to like what these guys are doing. Got my avg down to .52 which all things considered where I started, is not bad, doing some trading along the way. I'd like to pickup another 30K at a dime or better to bring avg down to .44 which is in the range where a rally that develops could hit allowing the opportunity to reduce some risk. The restricted shares continue to be a majority of the outstanding which is a good sign and there has really never been much dumping

👍️0

PennyStockTrader2 3年前

Picked up 15K at .11 bidding more, I really feel that at this price its a steal with market cap of 4 million bucks, and the CEO has a great track record, no game played, never late on filings, etc. This just needs more time. Share structure continues to be excellent with majority held by CEO and partner restricted

Market Cap Market Cap
4,247,283
05/15/2023
Authorized Shares
1,000,000,000
05/15/2023
Outstanding Shares
38,263,813
05/15/2023
Restricted
29,444,232
05/15/2023
Unrestricted
8,819,581
05/15/2023

👍️0

rhopton 3年前

seems a pump might be coming, unless it's already over.

👍️0

PennyStockTrader2 3年前

no idea I just saw it when you mentioned it. Geez I could have at least lightened up a little, thats what GTC orders are for. Things have been so dead for so long here

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Sigyn Therapeutics Inc (PK) (SIGY)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Sigyn Therapeutics Inc (PK) (SIGY) ニュース

Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

The $1.4 Trillion Cardiovascular Disease Crisis: Why Revolutionary Blood Purification Could Transform Treatment Access

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making

Form 8-K - Current report

Form 8-K - Current report

SIGY Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Sigyn Therapeutics Inc (PK) (SIGY)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Sigyn Therapeutics Inc (PK) (SIGY) ニュース

Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

The $1.4 Trillion Cardiovascular Disease Crisis: Why Revolutionary Blood Purification Could Transform Treatment Access

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making

Form 8-K - Current report

Form 8-K - Current report

SIGY Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する